Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | ACKR3 | P25106 | 9/20 | 0.44 |
| ▸ | HTR1F | P30939 | 3/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | HTR1D | P28221 | 1/20 | 0.42 |
| ▸ | HTR1B | P28222 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3530850 | 0.89 | KMT2A (0.45) | CYP1A2CYP3A4HTTEPHX2ACKR3 | |
| SCHEMBL5546827 | 0.84 | CYP1A2 (0.40) | CYP1A2CYP3A4HTTEPHX2ACKR3 | |
| SCHEMBL3530038 | 0.83 | HTT (0.46) | HTTACKR3ALDH1A1 | |
| SCHEMBL3534801 | 0.77 | CYP1A2 (0.48) | CYP1A2CYP3A4HTTKDM4EALDH1A1 | |
| SCHEMBL3527561 | 0.76 | CYP1A2 (0.45) | CYP1A2CYP3A4HTTHTR1FHTR1A | |
| SCHEMBL3530287 | 0.76 | CYP1A2 (0.48) | CYP1A2CYP3A4HTTHTR1FHTR1A | |
| SCHEMBL3531823 | 0.76 | CYP1A2 (0.47) | CYP1A2CYP3A4HTTACKR3HTR1F | |
| SCHEMBL3528366 | 0.76 | CYP1A2 (0.51) | CYP1A2CYP3A4HTTHTR1FHTR1A | |
| SCHEMBL3526674 | 0.75 | CYP1A2 (0.46) | CYP1A2CYP3A4HTTKDM4EALDH1A1 | |
| SCHEMBL3532765 | 0.73 | CYP1A2 (0.42) | CYP1A2CYP3A4HTTHTR1FHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7662828-B2 | Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds | GRUENENTHAL GMBH (DE) | 2010-02-16 | — | — | US | disclosed |
| US-20090176811-A1 | Substituted 5,6,7,8-Tetrahydro-pyrido[4,3-d]pyrimidine-2-yl Compounds and 5,6,7,8-Tetrahydro-quinazoline-2-yl Compounds | GRUENENTHAL GMBH (DE) | 2009-07-09 | — | — | US | disclosed |
| US-20070249631-A1 | Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds | GRUENENTHAL GMBH (DE) | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249631-A1 | Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds | P2RX7, CYP2C8, P2RX5 | CYP1A2 51/4885CYP3A4 43/4885HTT 858/4885 |
| US-20090176811-A1 | Substituted 5,6,7,8-Tetrahydro-pyrido[4,3-d]pyrimidine-2-yl Compounds and 5,6,7,8-Tetrahydro-quinazoline-2-yl Compounds | P2RX7, P2RX5, DPYD | CYP1A2 47/4885CYP3A4 52/4885HTT 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.